Dry Powder Inhalers (DPI)

Abstract Background/Objectives: This study aims to investigate the underexplored impact of cap- sule type on the performances of capsule-based dry...

Abstract Background/Objectives: Accurate determination of active pharmaceutical ingredient (API) particle size within dry powder inhaler (DPI) formulations is essential for ensuring...

Abstract Background/Objectives: The development of dry powder formulations for pulmonary delivery of therapeutic antibodies requires careful stabilization strategies to preserve...

Abstract Environmental relative humidity (RH) and temperature (T) are known to be promoters of physicochemical changes in pharmaceutical grade lactose,...

Abstract Background/Objectives: Reproducible evaluation of aerosol dispersibility remains a key challenge in the development of dry powder inhalers (DPIs), where small...

Abstract Despite being subject to a multitude of investigations, the effect of carrier particle size on the performance of adhesive...

Abstract Lower respiratory tract infections (LRTIs) constitute the fourth leading cause of mortality worldwide, resulting in over two million deaths...

Abstract Background/Objectives: This study aims to investigate the underexplored impact of capsule type on the performances of capsule-based dry powder...

Abstract Dry Powder Inhaler (DPI) formulations generally consist of drug particles with a size between 1 and 5 µm, ideal for...

Abstract Magnesium stearate (MgSt) has been used as a force control agent (FCA) to enhance the aerosol performance of carrier-based...